Monoclonal antibodies for prophylactic and therapeutic use against viral infections
Open Access
- 29 January 2013
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 31 (12), 1553-1559
- https://doi.org/10.1016/j.vaccine.2013.01.025
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Enhanced HIV-1 neutralization by antibody heteroligationProceedings of the National Academy of Sciences of the United States of America, 2012
- Analysis of Respiratory Syncytial Virus Preclinical and Clinical Variants Resistant to Neutralization by Monoclonal Antibodies Palivizumab and/or MotavizumabThe Journal of Infectious Diseases, 2011
- Escape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome CoronavirusThe Journal of Infectious Diseases, 2010
- Monoclonal antibody-based therapies for microbial diseasesVaccine, 2009
- Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10Proceedings of the National Academy of Sciences of the United States of America, 2009
- CCR5 monoclonal antibodies for HIV-1 therapyCurrent Opinion in HIV and AIDS, 2009
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesNature Structural & Molecular Biology, 2009
- In vitro selection of a neutralization-resistant hepatitis C virus escape mutantProceedings of the National Academy of Sciences of the United States of America, 2008
- Antibodies against viruses: passive and active immunizationCurrent Opinion in Immunology, 2008
- West Nile virus–induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neuronsJournal of NeuroVirology, 2008